Home › Funds › MONTGOMERY INVESTMENT MANAGEMENT INC › ABT

MONTGOMERY INVESTMENT MANAGEMENT INC position in ABT

ABBOTT LABORATORIES · Health Care

MONTGOMERY INVESTMENT MANAGEMENT INC reported holding 14,475 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 0.44% of its reported portfolio and ranking #39 among its reported holdings. MONTGOMERY INVESTMENT MANAGEMENT INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)14.47K sh
Reported value held$1.43M
Portfolio Weight0.44%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MONTGOMERY INVESTMENT MANAGEMENT INC's ABT position evolved

MONTGOMERY INVESTMENT MANAGEMENT INC first disclosed a stake in ABT in Q3 2023 at 18,748 shares (US$1.8M). The position peaked in Q1 2025 at 16,275 shares, worth US$2.2M. Across 13 filings, MONTGOMERY INVESTMENT MANAGEMENT INC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 14,475 shares valued at US$1.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 18.75K $1.82M New
Q4 2023 18.64K $2.05M Reduce
Q1 2024 16.23K $1.85M Reduce
Q2 2024 16.23K $1.69M Hold
Q3 2024 16.23K $1.85M Hold
Q4 2024 16.23K $1.84M Hold
Q1 2025 16.27K $2.16M Hold
Q2 2025 14.78K $2.01M Reduce
Q3 2025 14.72K $1.97M Hold
Q4 2025 14.72K $1.84M Hold
Q1 2026 14.72K $1.51M Hold
Q2 2026 14.47K $1.31M Reduce
Q3 2026 14.47K $1.43M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has MONTGOMERY INVESTMENT MANAGEMENT INC held ABT?

MONTGOMERY INVESTMENT MANAGEMENT INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MONTGOMERY INVESTMENT MANAGEMENT INC's current position in ABT?

As of Q3 2026, MONTGOMERY INVESTMENT MANAGEMENT INC holds 14.47K shares of ABT (ABBOTT LABORATORIES), valued at $1.43M, representing 0.44% of its reported portfolio and ranking #39.

Has MONTGOMERY INVESTMENT MANAGEMENT INC been buying or selling ABT?

In the latest 13F filing (Q3 2026), MONTGOMERY INVESTMENT MANAGEMENT INC held unchanged its position in ABT. The position peaked in Q1 2025 at 16.27K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.